Infectious diseases of humans: Dynamics and control

[1]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[2]  H. von Boehmer,et al.  CD4+8− help prevents rapid deletion of CD8+ cells after a transient response to antigen , 1993, European journal of immunology.

[3]  D. McConkey,et al.  Killing of immature CD4+CD8+ thymocytes in vivo by anti‐CD3 or 5′‐(N‐ethyl)‐carboxamido‐adenosine is blocked by glucocorticoid receptor antagonist RU‐486 , 1993, European journal of immunology.

[4]  H. Macdonald,et al.  Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus , 1993, The Journal of experimental medicine.

[5]  G. Kroemer,et al.  Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo , 1993, The Journal of experimental medicine.

[6]  B. Rocha,et al.  Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen , 1993, The Journal of experimental medicine.

[7]  J. Todd,et al.  Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. , 1993, Science.

[8]  P. Franchimont,et al.  Thymic neurohypophysial-related peptides and T cell selection , 1993, Regulatory Peptides.

[9]  S. Orrenius,et al.  Cyclic AMP potentiates glucocorticoid‐induced endogenous endonuclease activation in thymocytes 1 , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  V. Geenen,et al.  Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. , 1993, Thymus.

[11]  J. Seidman,et al.  Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors. , 1993, Science.

[12]  J. Swinton,et al.  Dynamic interaction between Leishmania infection in mice and Th1‐type CD4+ T‐cells: complexity in outcome without a requirement for Th2‐type responses , 1993, Parasite immunology.

[13]  S. Cobbold,et al.  Reprogramming the Immune System for Peripheral Tolerance with CD4 and CD8 Monoclonal Antibodies , 1992, Immunological reviews.